Obesity Correlation With Metastases Development and Response to First-Line Metastatic Chemotherapy in Breast Cancer

Obesity Correlation With Metastases Development and Response to First-Line Metastatic Chemotherapy in Breast Cancer

Show other versions (1)

Bibliographic Details
Main Authors:	Mohammed A. Osman, Bryan T. Hennessy
Format:	Article
Language:	English
Published:	SAGE Publishing 2015-11-01
Series:	Clinical Medicine Insights: Oncology
Online Access:	http://www.la-press.com/obesity-correlation-with-metastases-development-and-response-to-first--article-a5221

Similar Items

Obesity Correlation with Metastases Development and Response to First-Line Metastatic Chemotherapy in Breast Cancer
by: Mohammed A. Osman, et al.
Published: (2015-01-01)

Chemotherapy Options beyond the First Line in HER-Negative Metastatic Breast Cancer
by: Vito Lorusso, et al.
Published: (2020-01-01)

Extending the duration of first-line chemotherapy in metastatic breast cancer: a perspective review
by: Alessandra Gennari, et al.
Published: (2011-09-01)

Biomarkers for evaluating response to chemotherapy in metastatic breast cancer patients
by: Nidhal A.K. Mohammed Ali, et al.
Published: (2017-07-01)

The Outcome Of Antracycline-Based Combination Chemotherapy In Metastatic Breast Cancer As A First-Line Treatment
by: Ahmet Dirier, et al.
Published: (2003-03-01)

Phase I/II Trial of Sorafenib in Combination with Vinorelbine as First-Line Chemotherapy for Metastatic Breast Cancer.
by: Cristiano Ferrario, et al.
Published: (2016-01-01)

A phase II study of gemcitabine combined with vinorelbine as first-line chemotherapy for metastatic breast cancer
by: Samir Shehata, et al.
Published: (2010-01-01)

CAPECITABINE AND IRINOTECAN AS FIRST- LINE CHEMOTHERAPY FOR PATIENTS WITH METASTATIC COLORECTAL CANCER
by: Deyan Davidov
Published: (2010-11-01)

Clinical Outcomes with First-line Endocrine Therapy or Chemotherapy in Postmenopausal HR+/HER2- Metastatic Breast Cancer
by: Yan Song, et al.
Published: (2015-09-01)

Clinical Outcomes with First-line Endocrine Therapy or Chemotherapy in Postmenopausal HR+/HER2-Metastatic Breast Cancer
by: Yan Song, et al.
Published: (2015-01-01)

First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma
by: Bongiovanni A, et al.
Published: (2015-12-01)

Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer
by: S Whyte, et al.
Published: (2010-10-01)

PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH FIRST - LINE CHEMOTHERAPY
by: Deyan Davidov
Published: (2017-05-01)

Optimizing Economic Evaluation of First-Line Chemotherapies for Metastatic Pancreatic Cancer for the UK and the US
by: Gharaibeh, Mahdi, et al.
Published: (2016)

First-Line Doublet Chemotherapy for Metastatic Triple-Negative Breast Cancer: Circulating Tumor Cell Analysis of the tnAcity Trial
by: Liu MC, et al.
Published: (2019-12-01)

MAINTENANCE HORMONAL TREATMENT IMPROVES PROGRESSION FREE SURVIVAL AFTER A FIRST LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC BREAST CANCER
by: Armelle Dufresne, Xavier Pivot, Christophe Tournigand, Thomas Facchini, Thierry Alweeg, Loic Chaigneau, Aimery De Gramont
Published: (2008-01-01)

Role of lapatinib in the first-line treatment of patients with metastatic breast cancer
by: Catherine Oakman, et al.
Published: (2010-01-01)

Metastatic Urothelial Tumor Progression Following First Line Chemotherapy: Prognostic Factors and Importance of Second Line Chemotherapy
by: Mohammad S. Ma’koseh, et al.
Published: (2018-07-01)

First-line chemotherapy of advanced or metastatic breast cancer (MBC) with docetaxel and doxorubicin in Indonesia: results from A phase II trial
by: Abdulmuthalib Abdulmuthalib, et al.
Published: (2005-02-01)

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience
by: Maltoni Roberta, et al.
Published: (2006-03-01)

Chemotherapy options for metastatic colorectal carcinoma: First, second, third line...
by: Tomašević Zorica I., et al.
Published: (2003-01-01)

Occurrence and Characteristics of Hospitalizations During First-Line Chemotherapy Among Individuals with Metastatic Colorectal Cancer
by: Fisch MJ, et al.
Published: (2020-03-01)

The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreatic cancer
by: Zhi-Qiang Wang, et al.
Published: (2019-05-01)

Principles of Monitoring Metastatic Disease and Chemotherapy Regimens for Recurrent or Metastatic Breast Cancer
by: NCCN Clinical Practice Guidelines in Oncology: Breast Cancer (Version 1.213)
Published: (2013-06-01)

RISK FACTORS FOR THE DEVELOPMENT OF BRAIN METASTASES IN PATIENTS WITH METASTATIC BREAST CANCER
by: Hayder Abdulsamad, et al.
Published: (2021-06-01)

The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases
by: Amélie Darlix, et al.
Published: (2019-01-01)

The effect of chemotherapy and cetuximab on the number and size of liver metastases in breast cancer
by: Baltić Vladimir
Published: (2005-01-01)

ROLE OF PERIOPERATIVE CHEMOTHERAPY IN COMBINED TREATMENT OF METASTATIC COLORECTAL CANCER WITH ISOLATED LUNG OR LIVER METASTASES
by: L. V. Bolotina, et al.
Published: (2015-02-01)

RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients
by: Jiannan Yao, et al.
Published: (2018-01-01)

Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer
by: Hwang Jun-Eul, et al.
Published: (2011-11-01)

Efficacy of Bevacizumab-Capecitabine in Combination for the First-Line Treatment of Metastatic Breast Cancer
by: Stephen Dyar, et al.
Published: (2011-01-01)

Efficacy of Bevacizumab-Capecitabine in Combination for the First-Line Treatment of Metastatic Breast Cancer
by: Stephen Dyar, et al.
Published: (2011-11-01)

Outcome beyond third-line chemotherapy for metastatic triple-negative breast cancer in the French ESME program
by: Luc Cabel, et al.
Published: (2021-04-01)

Bevacizumab based chemotherapy in first line treatment of HER2 negative metastatic breast cancer: results of a Moroccan observational institutional study
by: Boulaamane Lamiaa, et al.
Published: (2012-03-01)

Pharmacoeconomic evaluation of the use of targeted therapy and chemotherapy in the first- and second-line therapies for metastatic colorectal cancer
by: A. A. Tryakin, et al.
Published: (2018-11-01)

Evolution of RAS Mutational Status in Liquid Biopsies During First-Line Chemotherapy for Metastatic Colorectal Cancer
by: Susanne Klein-Scory, et al.
Published: (2020-07-01)

No evidence for changes in skeletal muscle mass or weight during first-line chemotherapy for metastatic colorectal cancer
by: Sami Antoun, et al.
Published: (2019-08-01)

NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients.
by: Marta Schirripa, et al.
Published: (2018-01-01)

The use of atezolizumab in combination with chemotherapy in first-line of metastatic small cell lung cancer. Case report
by: Nikolai A. Ognerubov, et al.
Published: (2021-08-01)

Sequential Metastatic Breast Cancer Chemotherapy:Should the Median be the Message?
by: Su Yon eJung, et al.
Published: (2013-11-01)

Cannot write session to /tmp/vufind_sessions/sess_6k193rvl0d32g6ukq5esqes5cn